244 related articles for article (PubMed ID: 1688377)
21. Myasthenia gravis: effect on antibody binding of conservative substitutions of amino acid residues forming the main immunogenic region of the nicotinic acetylcholine receptor.
Wahlsten JL; Lindstrom JM; Ostlie N; Wu XD; Conti-Tronconi BM
J Recept Res; 1993; 13(5):863-79. PubMed ID: 8463998
[TBL] [Abstract][Full Text] [Related]
22. Precise epitope mapping of monoclonal antibodies to the cytoplasmic side of the acetylcholine receptor alpha subunit. Dissecting a potentially myasthenogenic epitope.
Tzartos SJ; Remoundos MS
Eur J Biochem; 1992 Aug; 207(3):915-22. PubMed ID: 1379917
[TBL] [Abstract][Full Text] [Related]
23. The main immunogenic region (MIR) of the nicotinic acetylcholine receptor and the anti-MIR antibodies.
Tzartos SJ; Cung MT; Demange P; Loutrari H; Mamalaki A; Marraud M; Papadouli I; Sakarellos C; Tsikaris V
Mol Neurobiol; 1991; 5(1):1-29. PubMed ID: 1725702
[TBL] [Abstract][Full Text] [Related]
24. Profile of the continuous antigenic regions on the extracellular part of the alpha chain of an acetylcholine receptor.
Mulac-Jericević B; Kurisaki J; Atassi MZ
Proc Natl Acad Sci U S A; 1987 Jun; 84(11):3633-7. PubMed ID: 2438685
[TBL] [Abstract][Full Text] [Related]
25. Binding of monoclonal antibodies against the carboxyl terminal segment of the nicotinic receptor delta subunit suggests an unusual transmembrane disposition of this sequence region.
Lei S; Okita DK; Conti-Fine BM
Biochemistry; 1995 May; 34(20):6675-88. PubMed ID: 7756299
[TBL] [Abstract][Full Text] [Related]
26. Amino acid residues within the sequence region alpha 55-74 of Torpedo nicotinic acetylcholine receptor interacting with antibodies to the main immunogenic region and with snake alpha-neurotoxins.
Wahlsten JL; Lindstrom JM; Conti-Tronconi BM
J Recept Res; 1993; 13(6):989-1008. PubMed ID: 8510074
[TBL] [Abstract][Full Text] [Related]
27. Reconstitution of conformationally dependent epitopes on the N-terminal extracellular domain of the human muscle acetylcholine receptor alpha subunit expressed in Escherichia coli: implications for myasthenia gravis therapeutic approaches.
Tsouloufis T; Mamalaki A; Remoundos M; Tzartos SJ
Int Immunol; 2000 Sep; 12(9):1255-65. PubMed ID: 10967020
[TBL] [Abstract][Full Text] [Related]
28. T-helper epitopes on human nicotinic acetylcholine receptor in myasthenia gravis.
Moiola L; Protti MP; Manfredi AA; Yuen MH; Howard JF; Conti-Tronconi BM
Ann N Y Acad Sci; 1993 Jun; 681():198-218. PubMed ID: 7689306
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis, and characterization of a 39 amino acid peptide mimic of the main immunogenic region of the Torpedo acetylcholine receptor.
Trinh VB; Foster AJ; Fairclough RH
Mol Immunol; 2014 May; 59(1):79-90. PubMed ID: 24491490
[TBL] [Abstract][Full Text] [Related]
30. Identification of regions involved in the binding of alpha-bungarotoxin to the human alpha7 neuronal nicotinic acetylcholine receptor using synthetic peptides.
Marinou M; Tzartos SJ
Biochem J; 2003 Jun; 372(Pt 2):543-54. PubMed ID: 12614199
[TBL] [Abstract][Full Text] [Related]
31. Passive transfer of experimental autoimmune myasthenia gravis by monoclonal antibodies to the main immunogenic region of the acetylcholine receptor.
Tzartos S; Hochschwender S; Vasquez P; Lindstrom J
J Neuroimmunol; 1987 Jun; 15(2):185-94. PubMed ID: 3495549
[TBL] [Abstract][Full Text] [Related]
32. Role of the main immunogenic region of acetylcholine receptor in myasthenia gravis. An Fab monoclonal antibody protects against antigenic modulation by human sera.
Tzartos SJ; Sophianos D; Efthimiadis A
J Immunol; 1985 Apr; 134(4):2343-9. PubMed ID: 3973387
[TBL] [Abstract][Full Text] [Related]
33. Structure and transmembrane nature of the acetylcholine receptor in amphibian skeletal muscle as revealed by cross-reacting monoclonal antibodies.
Sargent PB; Hedges BE; Tsavaler L; Clemmons L; Tzartos S; Lindstrom JM
J Cell Biol; 1984 Feb; 98(2):609-18. PubMed ID: 6363425
[TBL] [Abstract][Full Text] [Related]
34. The antigenic structure of the acetylcholine receptor from Torpedo californica.
Gullick WJ; Lindstrom JM
J Cell Biochem; 1982; 19(3):223-30. PubMed ID: 6185511
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of an antigenic site of native acetylcholine receptor peptide 159-169 of Torpedo acetylcholine receptor alpha-chain.
McCormick DJ; Lennon VA; Atassi MZ
Biochem J; 1985 Feb; 226(1):193-7. PubMed ID: 2579640
[TBL] [Abstract][Full Text] [Related]
36. Monoclonal antibodies as site-specific probes for the acetylcholine-receptor delta-subunit tyrosine and serine phosphorylation sites.
Tzartos SJ; Kouvatsou R; Tzartos E
Eur J Biochem; 1995 Mar; 228(2):463-72. PubMed ID: 7705363
[TBL] [Abstract][Full Text] [Related]
37. Compared structures of the free nicotinic acetylcholine receptor main immunogenic region (MIR) decapeptide and the antibody-bound [A76]MIR analogue: a molecular dynamics simulation from two-dimensional NMR data.
Orlewski P; Marraud M; Cung MT; Tsikaris V; Sakarellos-Daitsiotis M; Sakarellos C; Vatzaki E; Tzartos SJ
Biopolymers; 1996; 40(5):419-32. PubMed ID: 9062066
[TBL] [Abstract][Full Text] [Related]
38. Construction and characterization of a humanized single chain Fv antibody fragment against the main immunogenic region of the acetylcholine receptor.
Papanastasiou D; Mamalaki A; Eliopoulos E; Poulas K; Liolitsas C; Tzartos SJ
J Neuroimmunol; 1999 Feb; 94(1-2):182-95. PubMed ID: 10376952
[TBL] [Abstract][Full Text] [Related]
39. Epitope mapping employing antibodies raised against short synthetic peptides: a study of the nicotinic acetylcholine receptor.
Maelicke A; Plümer-Wilk R; Fels G; Spencer SR; Engelhard M; Veltel D; Conti-Tronconi BM
Biochemistry; 1989 Feb; 28(3):1396-405. PubMed ID: 2469469
[TBL] [Abstract][Full Text] [Related]
40. Pathogenesis of myasthenia gravis. Acetylcholine receptor-related antigenic determinants in tumor-free thymuses and thymic epithelial tumors.
Kirchner T; Tzartos S; Hoppe F; Schalke B; Wekerle H; Müller-Hermelink HK
Am J Pathol; 1988 Feb; 130(2):268-80. PubMed ID: 2449082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
